Aurinia Pharmaceuticals I... (AUPH)

NASDAQ: AUPH · Real-Time Price · USD

8.21

-0.03 (-0.36%)

At close: May 01, 2025, 3:59 PM

8.28

0.85%

Pre-market: May 02, 2025, 08:50 AM EDT

Aurinia Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	83.43M	48.88M	94.17M	231.9M	272.35M	306.02M	117.97M	165.63M	39.65M
Short-Term Investments	275.04M	301.61M	295.22M	234.18M	125.98M	n/a	7.89M	7.83M	n/a
Long-Term Investments	n/a	201K	n/a	n/a	24.38M	n/a	n/a	n/a	n/a
Other Long-Term Assets	823K	1.52M	13.34M	11.84M	247K	209K	358K	448K	n/a
Receivables	36.54M	24.09M	13.48M	15.41M	n/a	368K	217K	109K	86K
Inventory	39.23M	39.7M	24.75M	19.33M	13.93M	n/a	n/a	-109K	1.00
Other Current Assets	1.13M	1.03M	1.33M	796K	1.42M	n/a	n/a	n/a	n/a
Total Current Assets	446.6M	424.8M	442.54M	513.32M	419.43M	315.14M	132.85M	175.25M	41.42M
Property-Plant & Equipment	98.87M	116.57M	8.56M	9.8M	10.28M	93K	41K	31K	29K
Goodwill & Intangibles	4.36M	4.98M	6.42M	8.4M	9.33M	11.24M	12.62M	14.12M	15.55M
Total Long-Term Assets	104.05M	123.26M	28.32M	30.04M	44.23M	11.55M	13.02M	14.6M	15.58M
Total Assets	550.64M	548.06M	470.86M	543.37M	463.66M	326.68M	145.86M	189.85M	57M
Account Payables	5.19M	4.33M	3.09M	3.88M	2.63M	4.15M	2.95M	3.77M	2.86M
Deferred Revenue	11M	4.81M	3.15M	31.07M	21.37M	118K	118K	118K	118K
Short-Term Debt	15.07M	26.91M	936K	1.06M	788K	n/a	n/a	n/a	n/a
Other Current Liabilities	66.5M	29.3M	17.22M	16.41M	5.62M	3.28M	1.92M	2.22M	3.78M
Total Current Liabilities	97.76M	77.19M	46.11M	40.65M	32M	11.29M	7.26M	8.15M	7.93M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	75.4M	10.91M	12.17M	15.95M	16.3M	14.41M	25.7M	15.51M	12.56M
Total Long-Term Liabilities	75.4M	92.92M	19.32M	23.63M	23.91M	41.87M	26.03M	15.95M	13.12M
Total Liabilities	173.17M	170.11M	65.42M	64.28M	55.91M	53.17M	33.29M	24.1M	21.05M
Total Debt	79.37M	97.61M	8.09M	8.74M	8.41M	n/a	n/a	n/a	n/a
Common Stock	1.19B	1.2B	1.19B	1.18B	944.33M	790.47M	504.65M	499.2M	299.81M
Retained Earnings	-936.57M	-942.32M	-864.3M	-756.12M	-575.16M	-539.81M	-415.96M	-351.84M	-281.05M
Comprehensive Income	-647K	-730K	-1.06M	-852K	-805K	-805K	-805K	-883K	-805K
Shareholders Equity	377.48M	377.95M	405.44M	479.09M	407.75M	273.52M	112.58M	165.74M	35.95M
Total Investments	275.04M	301.81M	295.22M	234.18M	150.36M	n/a	7.89M	7.83M	n/a